Marijuana Business Daily (MJBiz Daily), a media and events company that produces the world's largest cannabis business trade show (MJBizCon), announced the acquisition of Emerald Scientific's The Emerald Conference.
Marijuana Business Daily (MJBiz Daily), a media and events company that produces the world's largest cannabis business trade show (MJBizCon), announced the acquisition of Emerald Scientific's The Emerald Conference, a technical and comprehensive science conference in the cannabis industry (1).
"We believe science needs to be the backbone of the cannabis sector and that it will become a much bigger part of the industry, from the business side to regulations to healthcare to the international landscape. This acquisition ensures we will play a leading role in making that happen and fostering growth," said Chris Walsh, CEO of MJBizDaily, in a press release (1). "The Emerald Conference has become the go-to event for scientists, related businesses, researchers and healthcare professionals. We will now take it to next level."
According the announcement, MJBizDaily plans to expand and enhance the conference, boost education and networking opportunities, and drive science and research forward. The company will reportedly bolster its reach in the science community in other ways as well, leveraging its digital publishing assets, event portfolio, and additional resources to provide content, knowledge sharing, networking opportunities, and information on the latest research via a variety of formats and mediums.
Under the terms of the deal, Emerald Scientific will reportedly consult with MJBizDaily on science content and events as part of a multiyear partnership. It also will continue to have a prominent presence at The Emerald Conference and other science-related events that MJBizDaily produces.
"This is more than an acquisition-it's a strategic partnership that allows us to incorporate Emerald Scientific's thought leadership and market insights," Walsh said.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.